2026年
- March 31, 2026
- パチスロ インフィニット ストラトス Enters into License Agreement with BIODOL for Novel Neuropathic Pain Treatment
- March 25, 2026
- パチスロ インフィニット ストラトス Enter into Distribution and Promotion Agreement with Johnson & Johnson for SIRTURO
- February 26, 2026
- Notice Regarding the Introduction of a Mandate-Based Corporate Officer System and Changes in Corporate Officers
- February 4, 2026
- パチスロ インフィニット ストラトス Receives Regulatory Approval for influenza virus nucleic acid kit, GeneSoC FluAB Detection Kit
- February 4, 2026
- Consolidated Financial Results for the Nine Months Ended December 31, 2025 - Supplementary Information
- 1